These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 186539

  • 1. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK, Donahoe RM, Huang KY, Sass B, Peters RL, Kelloff GJ.
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [Abstract] [Full Text] [Related]

  • 2. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice.
    Kelloff GJ, Peters RL, Donahoe RM, Ghazzouli I, Sass B, Nims RM, Huebner RJ.
    Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922
    [Abstract] [Full Text] [Related]

  • 3. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB, Holden HT, Ting CC, Lavrin DL, Kirchner H.
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [Abstract] [Full Text] [Related]

  • 4. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 5. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J, Ziegler HW, Kölsch E.
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ, Howe ML.
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC, Kirchner H, Rodrigues D, Park JY, Herberman RB.
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [Abstract] [Full Text] [Related]

  • 8. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR.
    J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422
    [Abstract] [Full Text] [Related]

  • 9. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
    Carbone G, Pierotti MA, Boiocchi M, De Leo AB, Ballinari D, Radice P, Borrello MG, Meseguer A, Cernuschi A, Parmiani G.
    Cancer Res; 1985 Oct 15; 45(10):4980-5. PubMed ID: 2992769
    [Abstract] [Full Text] [Related]

  • 10. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC, Law LW.
    J Immunol; 1977 Apr 15; 118(4):1259-64. PubMed ID: 191534
    [Abstract] [Full Text] [Related]

  • 11. Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population.
    Zbar B, Terata N, Nagai A, Tanio Y, Hovis J.
    Cancer Res; 1984 Oct 15; 44(10):4622-9. PubMed ID: 6088041
    [Abstract] [Full Text] [Related]

  • 12. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD, Weinhold KJ, Huper G, Thiel K, Bolognesi DP.
    J Natl Cancer Inst; 1981 Jul 15; 67(1):123-30. PubMed ID: 6265678
    [Abstract] [Full Text] [Related]

  • 13. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB, Lane MA, Yagi MJ.
    J Immunol; 1975 Jul 15; 115(1):190-4. PubMed ID: 50346
    [Abstract] [Full Text] [Related]

  • 14. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA, Ruscetti SK, Longo DL, Jacobson S, Brown EJ, Zinn S, Kruisbeek AM.
    J Immunol; 1985 Jul 15; 135(1):703-13. PubMed ID: 2582053
    [Abstract] [Full Text] [Related]

  • 15. Tumor rejection mediated by an amphotropic murine leukemia virus.
    Zbar B, Nagai A, Terata N, Hovis J.
    Cancer Res; 1983 Jan 15; 43(1):46-53. PubMed ID: 6182993
    [Abstract] [Full Text] [Related]

  • 16. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec 15; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 17. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M, Yamaguchi H, Hosokawa M, Mizushima Y, Kobayashi H.
    J Natl Cancer Inst; 1981 Aug 15; 67(2):417-22. PubMed ID: 6267345
    [Abstract] [Full Text] [Related]

  • 18. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb 15; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 19. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE, Wallis S, Burton RC, Warner NL.
    J Immunol; 1976 Nov 15; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [Abstract] [Full Text] [Related]

  • 20. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA, Mentzer SJ, Maizel SE.
    Cancer Res; 1982 Feb 15; 42(2):397-404. PubMed ID: 7055792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.